DIMENSIONAL FUND ADVISORS LP

Position in LLY — ELI LILLY & Co

CIK 354204 AUSTIN, TX

Back to LLY Full portfolio

Position in LLY

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$3,583,354,934

-$469,879,512 QoQ

Shares Held

3,895,925

+3.3% QoQ

Ownership

0.414%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 83.6059472397441.ToString("F0")% Shared 7.132683509051124.ToString("F0")% None 9.261369251204785.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. LLY ranks #2 (21.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	15,832,514	$3,870,099,719
2	LLY	ELI LILLY & Co This page	3,895,925	$3,583,354,934
3	MRK	Merck & Co., Inc.	15,456,039	$1,859,206,929
4	ABBV	AbbVie Inc.	7,411,238	$1,611,870,150
5	NVS	Novartis AG	8,110,116	$1,238,820,217
6	AMGN	Amgen Inc	3,304,344	$1,162,633,435
7	BMY	Bristol Myers Squibb Co	18,762,589	$1,137,951,021
8	GILD	Gilead Sciences, Inc.	7,722,929	$1,076,344,612

All Filings in LLY

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,583,354,934	3,895,925	+3.3%	Shares	Sole	2026-05-07
2025-12-31	$4,053,234,446	3,771,573	+0.2%	Shares	Sole	2026-02-12
2025-09-30	$2,871,872,486	3,763,922	+2.0%	Shares	Sole	2025-11-12
2025-06-30	$2,876,671,494	3,690,264	-2.8%	Shares	Sole	2025-08-12
2025-03-31	$3,135,389,742	3,796,285	+2.5%	Shares	Sole	2025-05-13
2024-12-31	$2,858,103,804	3,702,207	+1.3%	Shares	Sole	2025-02-13
2024-09-30	$3,237,963,631	3,654,834	+2.1%	Shares	Sole	2024-11-07
2024-06-30	$3,242,233,681	3,581,075	+5.0%	Shares	Sole	2024-08-09
2024-03-31	$2,652,439,058	3,409,480	+0.4%	Shares	Sole	2024-05-10
2023-12-31	$1,979,535,694	3,395,896	+0.8%	Shares	Sole	2024-02-07
2023-09-30	$1,808,942,114	3,367,792	+1.6%	Shares	Sole	2023-11-09
2023-06-30	$1,555,121,732	3,315,966	+3.1%	Shares	Sole	2023-08-09
2023-03-31	$1,104,392,355	3,215,865	+0.9%	Shares	Defined	2023-05-12
2022-12-31	$1,165,735,988	3,186,464	+1.8%	Shares	Sole	2023-02-09
2022-09-30	$1,012,595,421	3,131,577	+2.0%	Shares	Sole	2022-11-10
2022-06-30	$995,474,936	3,070,274	+2.4%	Shares	Sole	2022-08-12
2022-03-31	$858,361,142	2,997,385	-0.3%	Shares	Defined	2022-05-13
2021-12-31	$830,818,935	3,007,816	+0.3%	Shares	Defined	2022-02-09
2021-09-30	$692,809,432	2,998,526	-0.6%	Shares	Defined	2021-11-12
2021-06-30	$692,337,210	3,016,457	+0.9%	Shares	Defined	2021-08-12
2021-03-31	$558,250,479	2,988,173	+0.8%	Shares	Defined	2021-05-14
2020-12-31	$500,365,950	2,963,551	+1.7%	Shares	Defined	2021-03-08
2020-09-30	$431,235,399	2,913,359	+1.8%	Shares	Defined	2020-11-12
2020-06-30	$469,913,204	2,862,183	+2.4%	Shares	Defined	2020-08-13
2020-03-31	$387,635,700	2,794,375	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.